Halozyme Therapeutics shares owned by Affinity Investment Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Affinity Investment Advisors
from 13F filings
Historical chart of Affinity Investment Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Affinity Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Affinity Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $328k | 8.9k | 36.96 |
| 2023-09-30 | $600k | 16k | 38.20 |
| 2023-06-30 | $584k | 16k | 36.07 |
| 2023-03-31 | $731k | 19k | 38.19 |
| 2022-12-31 | $1.1M | 19k | 56.90 |
| 2022-09-30 | $866k | 22k | 39.54 |
| 2022-06-30 | $964k | 22k | 44.02 |
| 2022-03-31 | $911k | 23k | 39.90 |
| 2021-12-31 | $945k | 24k | 40.19 |
| 2021-09-30 | $976k | 24k | 40.67 |
More positions owned by Affinity Investment Advisors
View all positions for Affinity Investment Advisors